Verse Blog · Mar 2026
Discusses clinician experience improvements and new software features in 2025.
Software platform for in-home healthcare
Public company, workplace, funding, and market signals
Updated Aug 16, 2026
Verse Medical is a New York–based software company building AI-enabled ordering software for durable medical equipment (DME) and in-home healthcare. Its platform helps providers, payors, and patients manage referrals, orders, coverage validation, and medical record validation across the DME workflow.
Primary product
AI-enabled DME ordering and care-management software for in-home healthcare
Founded
2018
Headquarters
New York, New York, United States
Team size
150-200
Work style
Flexible
Industry
Software Development
Sub-industry
Healthcare software / DME workflow automation
Offices
Business model
Leadership
Founder & CEO
Head of Strategy & Operations
Head of Product
Head of Customer Success
Talent Specialist
Chief of Staff
Sterling Strother
Head of Payor Relations
Peter Oh
Head of Talent
Eastin Bricco
Head of Engineering
Nathan Wilde
Head of RCM
Founders
Office of the CEO / Co-founder
Public materials emphasize mission-driven work, aggressive hiring, and building software that improves hospital-quality care at home. LinkedIn posts suggest a fast-growing, high-ownership environment with offices in NYC and SF.
Work style
Flexible
Compensation
Public evidence is limited. One LinkedIn hiring post referenced a Sales Development Representative role with $55K base / $95K OTE in NYC. No broader compensation policy was found.
Pricing
Not publicly disclosed; appears to be enterprise/B2B software with provider and payor contracts.
Differentiators
Technology
Customers
Competitors
Estimated monthly visits
55.5K
Traffic estimate as of Jun 2026
Verse Blog · Mar 2026
Discusses clinician experience improvements and new software features in 2025.
Verse Blog · Mar 2026
Founder & CEO Dhaivat Pandya describes Verse’s mission and 2025 operating progress.
Verse Blog · Mar 2026
Company review highlighting 2025 progress, including tripling facility partners, 95% retention of existing facility partners, and patient NPS of 73.
LinkedIn · Jan 2026
Company launched a new telehealth offering to close supply gaps and provide DME where clinically appropriate, extending its core platform across payor and provider partners.
StartupHub.ai · Jun 2025
Announced a $53M Series C for its AI-enabled DME ordering and coordination platform.
29 jobs at Verse Medical